Mirae Asset Global Etfs Holdings Ltd. Kymera Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 26,949 shares of KYMR stock, worth $1.17 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,949
Previous 24,570
9.68%
Holding current value
$1.17 Million
Previous $733,000
73.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$289 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$261 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$225 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$213 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$207 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.38B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...